Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs directed at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment options remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline We're https://financefeeds.com/yescoins-web3-expansion-continues-with-2-4m-prize-pool-and-public-sale-on-yescoin-foundation/